Herpes Cure Advocacy

NEWS! Members of the Herpes Cure Advocacy Board have recently published a new commentary in Sexually Transmitted Disease Journal on the Use of Herpes Simplex Virus Type-1 and Type-2 Antibody Tests for Targeted Screening for Genital Herpes. Read below:

We often hear headlines about breakthrough discoveries and promising new therapies for herpes — only to hear nothing more about them months or even years later. Why do so many promising antiherpetic drugs fail to reach patients? Why does drug development take so long, and where are the biggest bottlenecks? Most importantly, is there a way to accelerate the process?

...

For decades, people living with herpes have been told to “just live with it.”

But science is proving that answer is no longer acceptable.

Thanks to growing research momentum — including promising antiviral and gene-targeting therapies — we are closer than ever to transforming herpes treatment and moving toward a functional cure.

At Her...

There’s major progress happening in the fight against HSV-2. Assembly Biosciences (ASMB) has reported very promising interim results from two Phase 1b clinical studies testing their new investigational treatments for recurrent genital herpes — ABI-1179 and ABI-5366.

Here’s what stood out:

Key Clinical Results

ABI-1179 (weekly oral dosing):

This #GivingTuesday, we’re fighting stigma and pushing for real progress toward an HSV cure. Herpes affects billions, yet cure-focused research remains severely underfunded. A cure isn’t impossible — it’s overdue.

Your support helps fuel the science, amplify voices, and bring real hope to a community that deserves better.

Let’s change the future together.<...